O	O	0	4	Role	Role	B-NP	NN	O	0	ROOT	O
O	O	5	7	of	of	B-PP	IN	O	1	NMOD	O
O	O	8	17	ascorbate	ascorbate	B-NP	NN	O	2	PMOD	O
O	O	18	20	in	in	B-PP	IN	O	1	NMOD	O
O	O	21	24	the	the	B-NP	DT	O	6	NMOD	O
O	O	25	35	activation	activation	I-NP	NN	O	4	PMOD	O
O	O	36	38	of	of	B-PP	IN	O	6	NMOD	O
T8	B-Entity	39	41	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T8	I-Entity	41	42	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T8	I-Entity	42	48	kappaB	kappaB	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	49	51	by	by	B-PP	IN	O	6	NMOD	O
T1	B-Protein	52	58	tumour	tumour	B-NP	NN	B-protein	14	NMOD	B-protein
T1	I-Protein	59	67	necrosis	necrosis	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Protein	68	74	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T1	I-Protein	74	75	-	-	O	HYPH	O	16	P	O
T1	I-Protein	75	80	alpha	alpha	B-NP	NN	O	11	PMOD	O
O	O	81	83	in	in	B-PP	IN	O	16	NMOD	O
O	O	84	85	T	T	B-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	85	86	-	-	B-VP	HYPH	I-cell_type	20	NMOD	I-cell_type
O	O	86	91	cells	cell	B-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	91	92	.	.	O	.	O	1	P	O

O	O	94	97	The	The	B-NP	DT	O	3	NMOD	O
O	O	98	103	first	first	I-NP	JJ	O	3	NMOD	O
O	O	104	111	product	product	I-NP	NN	O	11	NMOD	O
O	O	112	114	of	of	B-PP	IN	O	3	NMOD	O
O	O	115	124	ascorbate	ascorbate	B-NP	NN	O	6	NMOD	O
O	O	125	134	oxidation	oxidation	I-NP	NN	O	4	PMOD	O
O	O	134	135	,	,	O	,	O	11	P	O
O	O	136	139	the	the	B-NP	DT	O	11	NMOD	O
O	O	140	149	ascorbate	ascorbate	I-NP	NN	O	11	NMOD	O
O	O	150	154	free	free	I-NP	JJ	O	11	NMOD	O
O	O	155	162	radical	radical	I-NP	NN	O	16	SUB	O
O	O	163	164	(	(	O	(	O	14	DEP	O
O	O	164	167	AFR	AFR	B-NP	NN	B-protein	14	DEP	B-protein
O	O	167	168	)	)	O	)	O	11	NMOD	O
O	O	168	169	,	,	O	,	O	11	P	O
O	O	170	174	acts	act	B-VP	VBZ	O	0	ROOT	O
O	O	175	177	in	in	B-PP	IN	O	16	VMOD	O
O	O	178	188	biological	biological	B-NP	JJ	O	19	NMOD	O
O	O	189	196	systems	system	I-NP	NNS	O	17	PMOD	O
O	O	197	203	mainly	mainly	B-ADVP	RB	O	21	PMOD	O
O	O	204	206	as	as	B-PP	IN	O	19	NMOD	O
O	O	207	209	an	an	B-NP	DT	O	23	NMOD	O
O	O	210	217	oxidant	oxidant	I-NP	NN	O	21	PMOD	O
O	O	217	218	,	,	O	,	O	16	P	O
O	O	219	222	and	and	O	CC	O	16	VMOD	O
O	O	223	230	through	through	B-PP	IN	O	16	VMOD	O
O	O	231	234	its	its	B-NP	PRP$	O	28	NMOD	O
O	O	235	239	role	role	I-NP	NN	O	26	PMOD	O
O	O	240	242	in	in	B-PP	IN	O	28	NMOD	O
O	O	243	246	the	the	B-NP	DT	O	34	NMOD	O
O	O	247	253	plasma	plasma	I-NP	NN	O	34	NMOD	O
O	O	254	262	membrane	membrane	I-NP	NN	O	34	NMOD	O
O	O	263	268	redox	redox	I-NP	NN	O	34	NMOD	O
O	O	269	275	system	system	I-NP	NN	O	29	PMOD	O
O	O	276	282	exerts	exert	B-VP	VBZ	O	16	VMOD	O
O	O	283	292	different	different	B-NP	JJ	O	37	NMOD	O
O	O	293	300	effects	effect	I-NP	NNS	O	35	OBJ	O
O	O	301	303	on	on	B-PP	IN	O	35	VMOD	O
O	O	304	307	the	the	B-NP	DT	O	40	NMOD	O
O	O	308	312	cell	cell	I-NP	NN	O	38	PMOD	O
O	O	312	313	.	.	O	.	O	16	P	O

O	O	314	316	We	We	B-NP	PRP	O	2	SUB	O
O	O	317	321	have	have	B-VP	VBP	O	0	ROOT	O
O	O	322	334	investigated	investigate	I-VP	VBN	O	2	VC	O
O	O	335	338	the	the	B-NP	DT	O	5	NMOD	O
O	O	339	343	role	role	I-NP	NN	O	3	OBJ	O
O	O	344	346	of	of	B-PP	IN	O	5	NMOD	O
O	O	347	356	ascorbate	ascorbate	B-NP	NN	O	11	NMOD	O
O	O	356	357	,	,	O	,	O	11	P	O
O	O	358	361	AFR	AFR	B-NP	NN	O	11	NMOD	O
O	O	362	365	and	and	O	CC	O	11	NMOD	O
O	O	366	382	dehydroascorbate	dehydroascorbate	B-NP	NN	O	6	PMOD	O
O	O	383	384	(	(	O	(	O	14	DEP	O
O	O	384	387	DHA	DHA	B-NP	NN	O	14	DEP	O
O	O	387	388	)	)	O	)	O	11	NMOD	O
O	O	389	391	in	in	B-PP	IN	O	5	NMOD	O
O	O	392	395	the	the	B-NP	DT	O	17	NMOD	O
O	O	396	406	activation	activation	I-NP	NN	O	15	PMOD	O
O	O	407	409	of	of	B-PP	IN	O	17	NMOD	O
O	O	410	413	the	the	B-NP	DT	O	24	NMOD	O
T9	B-Entity	414	416	NF	NF	I-NP	NN	B-protein	24	NMOD	B-protein
T9	I-Entity	416	417	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T9	I-Entity	417	423	kappaB	kappaB	I-NP	NN	I-protein	24	NMOD	I-protein
T9	I-Entity	424	437	transcription	transcription	I-NP	NN	I-protein	24	NMOD	I-protein
T9	I-Entity	438	444	factor	factor	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	445	447	in	in	B-PP	IN	O	17	NMOD	O
O	O	448	454	Jurkat	Jurkat	B-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	455	456	T	T	I-NP	NN	I-cell_line	29	NMOD	I-cell_line
O	O	456	457	-	-	O	HYPH	I-cell_line	29	NMOD	I-cell_line
O	O	457	462	cells	cell	B-NP	NNS	I-cell_line	25	PMOD	I-cell_line
O	O	463	473	stimulated	stimulate	B-VP	VBN	O	29	NMOD	O
O	O	474	476	by	by	B-PP	IN	O	30	VMOD	O
T2	B-Protein	477	483	tumour	tumour	B-NP	NN	B-protein	34	NMOD	B-protein
T2	I-Protein	484	492	necrosis	necrosis	I-NP	NN	I-protein	34	NMOD	I-protein
T2	I-Protein	493	499	factor	factor	I-NP	NN	I-protein	36	NMOD	I-protein
T2	I-Protein	499	500	-	-	O	HYPH	O	36	P	O
T2	I-Protein	500	505	alpha	alpha	B-NP	SYM	O	31	PMOD	O
O	O	506	507	(	(	O	(	O	41	DEP	O
T3	B-Protein	507	510	TNF	TNF	B-NP	NN	B-protein	40	NMOD	B-protein
T3	I-Protein	510	511	-	-	O	HYPH	I-protein	40	P	I-protein
T3	I-Protein	511	516	alpha	alpha	B-NP	SYM	I-protein	41	DEP	I-protein
O	O	516	517	)	)	O	)	O	36	NMOD	O
O	O	517	518	.	.	O	.	O	2	P	O

O	O	519	523	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	524	526	we	we	B-NP	PRP	O	3	SUB	O
O	O	527	531	show	show	B-VP	VBP	O	0	ROOT	O
O	O	531	532	,	,	O	,	O	3	P	O
O	O	533	535	by	by	B-PP	IN	O	3	VMOD	O
O	O	536	551	electrophoretic	electrophoretic	B-NP	JJ	O	9	NMOD	O
O	O	552	560	mobility	mobility	I-NP	NN	O	9	NMOD	O
O	O	561	566	shift	shift	I-NP	NN	O	9	NMOD	O
O	O	567	573	assays	assay	I-NP	NNS	O	5	PMOD	O
O	O	573	574	,	,	O	,	O	3	P	O
O	O	575	579	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	580	589	ascorbate	ascorbate	B-NP	NN	O	13	SUB	O
O	O	590	599	increases	increase	B-VP	VBZ	O	11	SBAR	O
O	O	600	603	the	the	B-NP	DT	O	15	NMOD	O
O	O	604	611	binding	binding	I-NP	NN	O	13	OBJ	O
O	O	612	614	of	of	B-PP	IN	O	15	NMOD	O
T10	B-Entity	615	617	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T10	I-Entity	617	618	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T10	I-Entity	618	624	kappaB	kappaB	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	625	627	to	to	B-PP	TO	O	15	NMOD	O
T11	B-Entity	628	631	DNA	DNA	B-NP	NN	O	20	PMOD	O
O	O	632	634	in	in	B-PP	IN	O	15	NMOD	O
T4	B-Protein	635	638	TNF	TNF	B-NP	NN	B-protein	29	NMOD	B-protein
T4	I-Protein	638	639	-	-	B-NP	HYPH	O	29	P	O
T4	I-Protein	639	644	alpha	alpha	I-NP	SYM	O	27	AMOD	O
O	O	644	645	-	-	I-NP	HYPH	O	27	P	O
O	O	645	655	stimulated	stimulate	I-NP	VBN	O	29	NMOD	O
O	O	656	662	Jurkat	Jurkat	I-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	663	668	cells	cell	I-NP	NNS	I-cell_line	22	PMOD	I-cell_line
O	O	668	669	.	.	O	.	O	3	P	O

O	O	670	673	The	The	B-NP	DT	O	2	NMOD	O
O	O	674	681	ability	ability	I-NP	NN	O	12	SUB	O
O	O	682	684	of	of	B-PP	IN	O	2	NMOD	O
O	O	685	694	ascorbate	ascorbate	B-NP	NN	O	3	PMOD	O
O	O	695	697	to	to	B-VP	TO	O	6	VMOD	O
O	O	698	705	enhance	enhance	I-VP	VB	O	2	NMOD	O
O	O	706	717	cytoplasmic	cytoplasmic	B-NP	JJ	O	8	AMOD	O
O	O	718	728	inhibitory	inhibitory	I-NP	JJ	O	11	NMOD	O
T5	B-Protein	729	737	IkBalpha	IkBalpha	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	738	745	protein	protein	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	746	757	degradation	degradation	I-NP	NN	O	6	OBJ	O
O	O	758	768	correlates	correlate	B-VP	VBZ	O	0	ROOT	O
O	O	769	779	completely	completely	B-ADVP	RB	O	12	VMOD	O
O	O	780	784	with	with	B-PP	IN	O	12	VMOD	O
O	O	785	788	its	its	B-NP	PRP$	O	16	NMOD	O
O	O	789	797	capacity	capacity	I-NP	NN	O	14	PMOD	O
O	O	798	800	to	to	B-VP	TO	O	18	VMOD	O
O	O	801	807	induce	induce	I-VP	VB	O	16	NMOD	O
T12	B-Entity	808	810	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T12	I-Entity	810	811	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T12	I-Entity	811	817	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	818	825	binding	binding	I-NP	NN	O	18	OBJ	O
O	O	826	828	to	to	B-PP	TO	O	22	NMOD	O
T13	B-Entity	829	832	DNA	DNA	B-NP	NN	O	23	PMOD	O
O	O	833	836	and	and	O	CC	O	18	VMOD	O
O	O	837	839	to	to	B-VP	TO	O	27	VMOD	O
O	O	840	850	potentiate	potentiate	I-VP	VB	O	18	VMOD	O
T14	B-Entity	851	853	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
T14	I-Entity	853	854	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T14	I-Entity	854	860	kappaB	kappaB	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	860	861	-	-	O	HYPH	O	30	P	O
O	O	861	869	mediated	mediate	B-NP	VBN	O	33	NMOD	O
O	O	870	885	transactivation	transactivation	I-NP	NN	O	27	OBJ	O
O	O	886	888	of	of	B-PP	IN	O	33	NMOD	O
O	O	889	892	the	the	B-NP	DT	O	42	NMOD	O
T15	B-Entity	893	896	HIV	HIV	I-NP	NN	B-DNA	42	NMOD	B-DNA
T15	I-Entity	896	897	-	-	B-NP	HYPH	I-DNA	42	NMOD	I-DNA
T15	I-Entity	897	898	1	1	I-NP	CD	I-DNA	42	NMOD	I-DNA
T15	I-Entity	899	903	long	long	I-NP	JJ	I-DNA	42	NMOD	I-DNA
T15	I-Entity	904	912	terminal	terminal	I-NP	JJ	I-DNA	42	NMOD	I-DNA
T15	I-Entity	913	919	repeat	repeat	I-NP	NN	I-DNA	42	NMOD	I-DNA
T15	I-Entity	920	928	promoter	promoter	I-NP	NN	I-DNA	34	PMOD	I-DNA
O	O	929	931	in	in	B-PP	IN	O	33	NMOD	O
T6	B-Protein	932	935	TNF	TNF	B-NP	NN	B-protein	50	NMOD	B-protein
T6	I-Protein	935	936	-	-	B-NP	HYPH	O	50	P	O
T6	I-Protein	936	941	alpha	alpha	I-NP	SYM	O	50	NMOD	O
O	O	941	942	-	-	I-NP	HYPH	O	50	P	O
O	O	942	952	stimulated	stimulate	I-NP	VBN	O	50	NMOD	O
O	O	953	959	Jurkat	Jurkat	I-NP	NN	B-cell_line	50	NMOD	B-cell_line
O	O	960	965	cells	cell	I-NP	NNS	I-cell_line	43	PMOD	I-cell_line
O	O	966	969	but	but	B-PP	CC	O	43	PMOD	O
O	O	970	973	not	not	B-PP	RB	O	53	PMOD	O
O	O	974	976	in	in	I-PP	IN	O	43	PMOD	O
O	O	977	982	cells	cell	B-NP	NNS	O	53	PMOD	O
O	O	983	993	stimulated	stimulate	B-VP	VBN	O	54	NMOD	O
O	O	994	998	with	with	B-PP	IN	O	55	VMOD	O
O	O	999	1002	PMA	PMA	B-NP	NN	O	59	NMOD	O
O	O	1003	1007	plus	plus	B-NP	CC	O	59	NMOD	O
O	O	1008	1017	ionomycin	ionomycin	I-NP	NN	O	56	PMOD	O
O	O	1017	1018	.	.	O	.	O	12	P	O

O	O	1019	1022	AFR	AFR	B-NP	NN	O	2	SUB	O
O	O	1023	1030	behaves	behave	B-VP	VBZ	O	0	ROOT	O
O	O	1031	1035	like	like	B-PP	IN	O	2	VMOD	O
O	O	1036	1045	ascorbate	ascorbate	B-NP	NN	O	3	PMOD	O
O	O	1045	1046	,	,	O	,	O	2	P	O
O	O	1047	1052	while	while	B-SBAR	IN	O	2	VMOD	O
O	O	1053	1056	DHA	DHA	B-NP	NN	O	10	NMOD	O
O	O	1057	1060	and	and	I-NP	CC	O	10	NMOD	O
O	O	1061	1070	ascorbate	ascorbate	I-NP	NN	O	10	NMOD	O
O	O	1071	1080	phosphate	phosphate	I-NP	NN	O	11	SUB	O
O	O	1081	1083	do	do	B-VP	VBP	O	6	SBAR	O
O	O	1084	1087	not	not	I-VP	RB	O	11	VMOD	O
O	O	1088	1094	affect	affect	I-VP	VB	O	11	VC	O
T7	B-Protein	1095	1098	TNF	TNF	B-NP	NN	B-protein	18	NMOD	B-protein
T7	I-Protein	1098	1099	-	-	O	HYPH	O	14	P	O
T7	I-Protein	1099	1104	alpha	alpha	O	SYM	O	18	P	O
O	O	1104	1105	-	-	O	HYPH	O	18	P	O
O	O	1105	1113	mediated	mediate	B-NP	VBN	O	22	NMOD	O
T16	B-Entity	1114	1116	NF	NF	I-NP	NN	B-protein	21	NMOD	B-protein
T16	I-Entity	1116	1117	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T16	I-Entity	1117	1123	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	1124	1134	activation	activation	I-NP	NN	O	13	OBJ	O
O	O	1134	1135	.	.	O	.	O	2	P	O

O	O	1136	1141	These	These	B-NP	DT	O	2	NMOD	O
O	O	1142	1149	results	result	I-NP	NNS	O	3	SUB	O
O	O	1150	1157	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	1158	1161	new	new	B-NP	JJ	O	5	NMOD	O
O	O	1162	1170	evidence	evidence	I-NP	NN	O	3	OBJ	O
O	O	1171	1174	for	for	B-PP	IN	O	5	NMOD	O
O	O	1175	1176	a	a	B-NP	DT	O	9	NMOD	O
O	O	1177	1185	possible	possible	I-NP	JJ	O	9	NMOD	O
O	O	1186	1198	relationship	relationship	I-NP	NN	O	6	PMOD	O
O	O	1199	1206	between	between	B-PP	IN	O	9	NMOD	O
O	O	1207	1210	the	the	B-NP	DT	O	12	NMOD	O
O	O	1211	1221	activation	activation	I-NP	NN	O	10	PMOD	O
O	O	1222	1224	of	of	B-PP	IN	O	12	NMOD	O
O	O	1225	1228	the	the	B-NP	DT	O	18	NMOD	O
O	O	1229	1237	electron	electron	I-NP	NN	O	18	NMOD	O
O	O	1237	1238	-	-	I-NP	HYPH	O	18	NMOD	O
O	O	1238	1247	transport	transport	I-NP	NN	O	18	NMOD	O
O	O	1248	1254	system	system	I-NP	NN	O	13	PMOD	O
O	O	1255	1257	at	at	B-PP	IN	O	12	NMOD	O
O	O	1258	1261	the	the	B-NP	DT	O	22	NMOD	O
O	O	1262	1268	plasma	plasma	I-NP	NN	O	22	NMOD	O
O	O	1269	1277	membrane	membrane	I-NP	NN	O	19	PMOD	O
O	O	1278	1280	by	by	B-PP	IN	O	12	NMOD	O
O	O	1281	1290	ascorbate	ascorbate	B-NP	NN	O	28	NMOD	O
O	O	1291	1293	or	or	O	CC	O	28	NMOD	O
O	O	1294	1297	its	its	B-NP	PRP$	O	28	NMOD	O
O	O	1298	1302	free	free	I-NP	JJ	O	28	NMOD	O
O	O	1303	1310	radical	radical	I-NP	NN	O	34	NMOD	O
O	O	1311	1314	and	and	I-NP	CC	O	34	NMOD	O
O	O	1315	1320	redox	redox	I-NP	NN	O	34	NMOD	O
O	O	1320	1321	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	1321	1330	dependent	dependent	I-NP	JJ	O	34	NMOD	O
O	O	1331	1335	gene	gene	I-NP	NN	O	34	NMOD	O
O	O	1336	1349	transcription	transcription	I-NP	NN	O	23	PMOD	O
O	O	1350	1352	in	in	B-PP	IN	O	34	NMOD	O
O	O	1353	1354	T	T	B-NP	NN	B-cell_type	38	NMOD	B-cell_type
O	O	1354	1355	-	-	B-VP	HYPH	I-cell_type	38	NMOD	I-cell_type
O	O	1355	1360	cells	cell	B-NP	NNS	I-cell_type	35	PMOD	I-cell_type
O	O	1360	1361	.	.	O	.	O	3	P	O
